VIR BIOTECHNOLOGY INC (VIR)
US92764N1028 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -615.12M | 515.80M | 528.60M | -298.70M | -174.70M | |||
| Depreciation Amortization | 19.45M | 6.80M | 5.80M | 5.40M | 4.50M | |||
| Income Taxes - Deferred | -1.06M | -15.20M | 15.20M | -100.00K | N/A | |||
| Change In Working Capital | -304.59M | 665.40M | -628.40M | 29.50M | 8.20M | |||
| Taxes Paid | 2.68M | 252.00M | N/A | N/A | N/A | |||
| Other non cash items | 122.53M | 490.50M | 31.20M | 72.80M | 32.30M | |||
| OPERATING CASH FLOW | -778.78M | 1.66B | -47.60M | -190.90M | -129.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -21.57M | -68.00M | -21.80M | -6.50M | -8.90M | |||
| Other Investing Activity | 186.20M | -1.13B | -119.00M | -3.30M | -247.20M | |||
| INVESTING CASH FLOW | 164.63M | -1.19B | -140.80M | -9.90M | -256.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -287.00K | -300.00K | -300.00K | -300.00K | 4.40M | |||
| Stock Issued/Repurchased | 7.77M | 36.20M | 100.60M | 534.00M | 444.90M | |||
| Other Financing Activity | 0.00 | -1.20M | 0.00 | -4.20M | N/A | |||
| FINANCING CASH FLOW | 7.48M | 34.80M | 100.30M | 529.50M | 449.20M | |||
| CHANGE IN CASH | -606.68M | 504.60M | -88.10M | 328.70M | 63.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -778.78M | 1.66B | -47.60M | -190.90M | -129.60M | |||
| Capital Expenditure | -21.57M | -68.00M | -21.80M | -6.50M | -8.90M | |||
| FREE CASH FLOW | -800.36M | 1.60B | -69.40M | -197.40M | -138.50M | |||
All data in USD